USC Marshall School of Business | Groups




Marshall Consulting & Strategy Club


Global Teams  |  Global Companies  |  Global Challenges

2016 GCC Results!


Are you looking for a challenge where you can hone your consulting skills and solve a real-life issue facing a prominent firm?  Do you seek the opportunity to demonstrate your analytical and presentation skills in front of an expert audience interested in top MBA talent?  If so, then USC Marshall’s Global Consulting Challenge (GCC) is just the experience for you.

GCC consists of five weeks of preparation culminating in a two-day competition, which is like three competitions in one.  You and your team will work together to research and analyze the challenges facing the sponsoring firm and the trends in their industry.  You will be presented with three prompts: one focusing on the industry trends; one focusing on consulting methodology; and one focusing on a specific challenge the sponsor faces. On March 2nd 
and 3rd, you will be invited to present your findings to three independent panels of experts and compete against teams from some of the top MBA programs from around the globe for lucrative prizes.


The Opportunity

USC Marshall’s Global Consulting Challenge is a rewarding experience for a number of reasons.  Not only is it an excellent way to network with some of the brightest MBA students in the world, the competition also gives you and your team the opportunity to demonstrate your talent to some of the industry’s best experts.

The issues you will be asked to tackle are real and relevant, and will push you to develop out-of-the-box thinking. Your findings will have the potential not only to change the direction of a leading firm, but also the way things are done in an entire industry.  For example, the concept of “Roll-Over Minutes,” now an industry standard, emerged from the 2003 Global Consulting Challenge sponsored by Cingular Wireless.  


2017 Sponsor Company


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit